Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

The Journal of Infectious Diseases
Myron J LevinVeterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators

Abstract

A double-blind, placebo-controlled trial that involved 38,546 subjects > or =60 years old demonstrated efficacy of a high-potency live-attenuated Oka/Merck varicella-zoster virus (VZV) vaccine. The trial included an immunology substudy to determine the relationship of VZV-specific immune responses to vaccination and clinical outcome. The immunology substudy enrolled 1395 subjects at 2 sites where blood samples obtained prior to vaccination, at 6 weeks after vaccination, and at 1, 2, and 3 years thereafter were tested for VZV-specific cell-mediated immunity (VZV-CMI) by gamma-interferon ELISPOT and responder cell frequency assays and for VZV antibody by glycoprotein ELISA. VZV-CMI and VZV antibodies were significantly increased in vaccine recipients at 6 weeks after vaccination. The vaccine-induced increases in VZV-CMI persisted during the 3 years of follow-up, although their magnitude decreased over time. The magnitude of these VZV-specific immune responses was greater in subjects 60-69 years old than in subjects > or =70 years old. The zoster vaccine induced a significant increase in VZV-CMI and VZV antibody. The magnitude and duration of the boost in VZV-CMI in vaccine recipients and the relationship of this boost to age para...Continue Reading

References

Dec 1, 1979·The Journal of Infectious Diseases·M J LevinM S Hirsch
Aug 1, 1992·The Journal of Infectious Diseases·M J LevinA R Hayward
Nov 1, 1990·Journal of the American Geriatrics Society·K SchmaderH J Cohen
May 1, 1986·The Journal of Infectious Diseases·P LjungmanB Wahren
Sep 1, 1982·Medicine·M W RagozzinoH O Perry
Aug 7, 1995·Archives of Internal Medicine·J G DonahueR Platt
Mar 29, 1994·Journal of Immunological Methods·A R HaywardM J Levin
Sep 1, 1996·Infectious Disease Clinics of North America·M J Levin, A R Hayward
Oct 1, 1996·Pain·R H Dworkin, R K Portenoy
Aug 26, 1998·Journal of the American Geriatrics Society·K SchmaderC F Pieper
Dec 16, 1998·The Journal of Infectious Diseases·M IrwinM N Oxman
Jun 6, 1996·Health Policy·R Brooks
Mar 4, 2000·The New England Journal of Medicine·D H GildenR J Cohrs
Mar 13, 2001·Bone Marrow Transplantation·M J Laughlin
Apr 24, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Schmader
Jul 5, 2002·The New England Journal of Medicine·Atsuko HataAnn M Arvin
Aug 2, 2002·The New England Journal of Medicine·John W Gnann, Richard J Whitley
Sep 19, 2002·The Pediatric Infectious Disease Journal·Charles GroseAdel K Afifi
Jan 27, 2004·BMJ : British Medical Journal·S L ThomasAndrew J Hall
Jul 1, 1995·Clinical and Diagnostic Virology·M YoshidaM Hiruma
Jun 3, 2005·The New England Journal of Medicine·M N OxmanUNKNOWN Shingles Prevention Study Group

❮ Previous
Next ❯

Citations

Dec 12, 2012·Epidemiology and Infection·Y OkunoUNKNOWN Shozu Herpes Zoster (SHEZ) Study Group
Jul 9, 2011·Nature Immunology·Bali Pulendran, Rafi Ahmed
Jun 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley A Plotkin
Feb 23, 2010·The Journal of Infectious Diseases·Adriana WeinbergMyron J Levin
Mar 23, 2011·AIDS Research and Human Retroviruses·Nathalie De CastroJean-Michel Molina
Feb 1, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kenneth E SchmaderJanie Parrino
Feb 16, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael R IrwinMichael N Oxman
May 2, 2013·The Journal of Infectious Diseases·Vicki A MorrisonUNKNOWN Shingles Prevention Study Group
Aug 3, 2013·The Journal of Infectious Diseases·Myron J LevinJanie Parrino
Aug 3, 2013·The Journal of Infectious Diseases·Kathleen M MullanePaula W Annunziato
Jun 30, 2009·The Pediatric Infectious Disease Journal·Anne A GershonUNKNOWN Pediatric AIDS Clinical Trials Group 391 Team
Jan 10, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Myron J LevinUNKNOWN PACTG/IMPAACT 219C Team
May 14, 2010·Clinical and Vaccine Immunology : CVI·Stanley A Plotkin
Jul 8, 2010·Aging Health·Joel V Chua, Wilbur H Chen
Mar 12, 2010·Uirusu·Yoshizo Asano
Jan 7, 2014·European Journal of Internal Medicine·Susanna EspositoUNKNOWN ESCMID Vaccine Study Group (EVASG)
Aug 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Bali Pulendran
Jun 15, 2014·Drugs & Aging·Pierre-Olivier Lang, Richard Aspinall
Sep 23, 2014·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Travis RuddMark Glasgow
Jul 28, 2011·Journal of Neurovirology·Jennifer CanniffAdriana Weinberg
Aug 29, 2009·The Journal of Infectious Diseases·Adriana WeinbergUNKNOWN US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators
May 3, 2008·The Journal of Infectious Diseases·Jeffrey I Cohen
Jul 24, 2012·Zeitschrift für Gesundheitswissenschaften = Journal of public health·Kati LukasIsabelle Bertrand
Jun 4, 2014·Expert Review of Vaccines·Richard Aspinall, Pierre Olivier Lang
May 20, 2015·Expert Review of Ophthalmology·D J RoyerDjj Carr
Jul 25, 2009·Expert Review of Vaccines·Wolfgang Herr, Bodo Plachter
Aug 30, 2013·Expert Opinion on Biological Therapy·Hung Q DoanStephen K Tyring
Jul 3, 2013·The Medical Clinics of North America·Kim M O'Connor, Douglas S Paauw
Nov 28, 2012·Journal of Dermatological Science·Hideo AsadaUNKNOWN Shozu Herpes Zoster (SHEZ) Study group
Oct 11, 2015·The Journal of Infectious Diseases·D Scott Schmid
Jan 5, 2016·La Presse médicale·Nabila FerahtaPierre-Olivier Lang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Michael N OxmanShingles Prevention Study Group
The Journal of Infectious Diseases
Adriana WeinbergUS Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Michael N Oxman
© 2022 Meta ULC. All rights reserved